Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-11-019097
Filing Date
2011-04-07
Accepted
2011-04-07 13:35:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G a11-9923_4sc13g.htm SC 13G 71679
  Complete submission text file 0001104659-11-019097.txt   73302
Mailing Address 225 SOUTH LAKE AVE SUITE 400 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVE STE 400 PASADENA CA 91101-3005 8183049222
PRIMECAP MANAGEMENT CO/CA/ (Filed by) CIK: 0000763212 (see all company filings)

EIN.: 953868081
Type: SC 13G

Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Subject) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-45385 | Film No.: 11745700
SIC: 2834 Pharmaceutical Preparations